Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac<sup>®</sup> and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study.

Vaccines (Basel) · 2023 · PMC10146055 · PMID 37112627

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Even though serum albumin, Kt/Vurea values, dialysis vintage, and hemoglobin levels demonstrated similar impacts on the seroconversion rate as had been reported in previous publications, those variables did not reach statistical significance in this study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.